HCPCS code M1191
Hospice services provided to patient any time during the measurement period
What M1191 means
M1191 (Hspc svc any time in meas pd) belongs to the HCPCS Level II M series (Medical Services). Its Medicare coverage status is Carrier judgment. Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.
Part B pricing: Service not separately priced by Part B (e.g., services not covered, bundled, used by part a only, etc.).
Code details
- Short description
- Hspc svc any time in meas pd
- Coverage code
- C = Carrier judgment
- Pricing indicator
- 00 = Service not separately priced by Part B (e.g., services not covered, bundled, used by part a only, etc.)
- Multiple pricing indicator
- 9 = Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established(pricing indicator is '99')
- Type of service
- 1 = Medical care
- Action code
- N = No maintenance for this code
- Action effective date
- January 01, 2023
- Code added date
- January 01, 2023
- Data year
- 2026
Questions about M1191
What is HCPCS code M1191?
HCPCS code M1191 is a Level II code in the M series (Medical Services). Its full description is: "Hospice services provided to patient any time during the measurement period"
Is M1191 a CPT code?
No. M1191 is a HCPCS Level II code maintained by CMS, not a CPT (Level I) code from the American Medical Association. People often search for it as a CPT code because both code sets are reported on the same claims.
Does Medicare cover HCPCS code M1191?
The Medicare coverage code for M1191 is "Carrier judgment". Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.
When was HCPCS code M1191 added?
M1191 was added to the HCPCS code set on January 01, 2023. The most recent action on it (No maintenance for this code) took effect on January 01, 2023.
Nearby M codes
All M codes- M1186Patients who have an order for or are receiving hospice or palliative care
- M1187Patients with a diagnosis of end stage renal disease (esrd)
- M1188Patients with a diagnosis of chronic kidney disease (ckd) stage 5
- M1189Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
- M1190Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
- M1192Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
- M1193Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
- M1194Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
- M1195Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
- M1196Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4